Astaxanthin has the ability to significantly lower systolic blood pressure in rats, according to a new study performed at Georgetown University Medical Center.
Astaxanthin has the ability to significantly lower systolic blood pressure in rats, according to a new study performed at Georgetown University Medical Center. This study joins three other past studies performed at the Toyama Medical and Pharmaceutical University in Japan which researched astaxanthin’s ability to reduce hypertension as well mechanism of actions for this benefit.
In the Georgetown University study, tests suggested that the Renin-Angiotensin system was involved in the ability of astaxanthin to lower blood pressure. Also, at higher dosage levels it was shown that astaxanthin influenced circulating TNF-α and MCP-1 and lessened fat oxidation in the liver and kidneys. This is an indication that astaxanthin may help to reduce stress.
The study was sponsored by Fuji Chemical Industry (Japan) and performed using AstaREAL astaxanthin.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.